Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JULY 26, 2024 SAM #8277
SPECIAL NOTICE

65 -- NOTICE OF INTENT TO SOLE SOURCE - ILLUMINA REAGENTS

Notice Date
7/24/2024 1:20:41 PM
 
Notice Type
Special Notice
 
NAICS
424210 — Drugs and Druggists' Sundries Merchant Wholesalers
 
Contracting Office
CENTERS FOR DISEASE CONTROL AND PREVENTION Atlanta GA 30333 US
 
ZIP Code
30333
 
Solicitation Number
75D30124Q78095
 
Response Due
7/31/2024 2:00:00 PM
 
Archive Date
08/15/2024
 
Point of Contact
Jennifer Gartzke, Phone: 4044980020
 
E-Mail Address
xuy7@cdc.gov
(xuy7@cdc.gov)
 
Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc. for test kits. The products being purchased are for Illumina testing equipment, MiSeq, MiniSeq, and NextSeq instruments. Illumina is the only seller of the DNA prep library and sequencing kits for these instruments and does not have any additional authorized re-sellers in the United States. The only kits that are compatible with the instruments are those made by the manufacturer of the instruments and therefore the CDC must purchase the parts from Illumina, Inc. No other products were considered as no other products are compatible with these machines. Re-sellers were researched, but there are none in the United States; the closest re-seller is in Mexico. The continuity of sequencing influenza with the Illumina DNA prep library and sequencing kits on the Illumina sequencing platforms is critical for analyzing, comparing, and compiling influenza data with united states public health laboratories and the World Health Organization (WHO) Collaborating Centers in the World Health Organization Global Influenza Surveillance and Response Network (GISRS) who use the same kits, sequencing platforms and protocols. All data reports from WHO Collaborating Centers in the GISRS are analyzed at the biannual influenza vaccine meetings in Geneva, Switzerland, and are critical for selecting the influenza viruses used in the Northern and Southern Hemisphere annual influenza vaccines. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven days of the issuance of this notice will be considered by the government.� A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.� Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.� Any quotation/response should be emailed to contract specialist at xuy7@cdc.gov by 5:00 PM EDT July 31, 2024.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/22368c7aac114895acb5358be5495bc1/view)
 
Place of Performance
Address: Atlanta, GA, USA
Country: USA
 
Record
SN07140978-F 20240726/240724230111 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.